Tag: oligonucleotides
CNS innovator oligonucleotide licensing value surges by 339% to $2.8 billion...
According to GlobalData’s Pharmaceutical Intelligence Center Deals Database, licensing agreements for innovator oligonucleotides targeting CNS indications secured a cumulative total deal value of $6.05 billion from 2021 to 2025 YTD